• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 10CT; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 10CT; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 Back to Search Results
Catalog Number 195-170
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/20/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The remainder of the investigation is in progress.A supplemental report will be provided pending completion, or upon receipt of new information.
 
Event or Problem Description
The consumer reported multiple false positive results with the binaxnow covid-19 ag self test performed on various dates.This mfr.Report is four (4) of 4 (four).The consumer reported a false positive result with the binaxnow covid-19 ag self test performed on (b)(6) 2024 with nasal sample type.Additional testing was performed using flow flex test with unknow sample type on (b)(6) 2024 which gave negative result.The consumer confirmed that she was asymptomatic and no patient harm due to the test results.
 
Event or Problem Description
The consumer reported multiple false positive results with the binaxnow covid-19 ag self test performed on various dates.This mfr.Report is four (4) of 4 (four).The consumer reported a false positive result with the binaxnow covid-19 ag self test performed on (b)(6) 2024 with nasal sample type.Additional testing was performed using flow flex test with unknow sample type on (b)(6) 2024 which gave negative result.The consumer confirmed that she was asymptomatic and no patient harm due to the test results.
 
Additional Manufacturer Narrative
Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 870972b with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for kit part number 195-170/ lot 870972b and device part number 195-430wjr/ lot 870972.The lot met the required release specifications.A review of the complaints reported as false positive patient results (confirmed and unconfirmed, conflicting results) related to kit lot 870972 showed that the complaint rate is (b)(4).Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 10CT
Common Device Name
LATERAL FLOW IMMUNOASSAY IVD OF COVID-19
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key20388113
Report Number1221359-2024-00637
Device Sequence Number6548783
Product Code QKP
UDI-Device Identifier00811877011118
UDI-Public01008118770111181726011210870972B
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
EUA210264
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 10/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date01/12/2026
Device Catalogue Number195-170
Device Lot Number870972B
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/25/2024
Supplement Date Received by Manufacturer10/15/2024
Initial Report FDA Received Date10/07/2024
Supplement Report FDA Received Date10/23/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/20/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age60 YR
Patient SexFemale
Patient Weight91 KG
Patient RaceWhite
-
-